Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

5 search results for ‘*’


Research Field Gene Editing

It's CRISPR Crunch Time

| Jonathan James

China drafts new gene-editing regulations – but concerns over their enforcement remain.


Outside the Lab Policy

Moving on from the Great CRISPR Controversy

| Jonathan James

How will the storm whipped up by He Juinkai’s flagrant disregard for medical ethics affect the wider ambitions of the gene-editing field?


Research Field Cell & gene therapy

Now For the High-Hanging Fruit

| Miguel Forte

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.


Disease Area Cancer

No-Biotics for Me!

| Gemma North

We don’t fully understand how probiotics affect cancer patient prognosis, so they should be approached with caution – at least for now.


Outside the Lab Public health

Medical Robotics Are the Future

| Jeremy Russell

As healthcare systems across the globe feel the strain of an increasing (and aging) population, we need someone – or rather something – to lend a help


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register